Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127000861 | 12700086 | 1 | I | 201401 | 20160819 | 20160830 | 20160830 | EXP | US-BAYER-2016-168433 | BAYER | 83.00 | YR | E | F | Y | 74.84000 | KG | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127000861 | 12700086 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | Y | N | 0 | 20 | MG | FILM-COATED TABLET | QD | ||||
| 127000861 | 12700086 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | Y | N | 0 | 20 | MG | FILM-COATED TABLET | QD | ||||
| 127000861 | 12700086 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Y | N | 0 | FILM-COATED TABLET | |||||||||
| 127000861 | 12700086 | 4 | SS | TYLENOL | ACETAMINOPHEN | 1 | Unknown | 1000 MG, Q6HR | 0 | 1000 | MG | ||||||||
| 127000861 | 12700086 | 5 | SS | DICLOFENAC | DICLOFENAC | 1 | Ophthalmic | 0.1 %, QD | Y | 0 | .1 | PCT | QD | ||||||
| 127000861 | 12700086 | 6 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG, QD | 0 | 75 | MG | QD | |||||||
| 127000861 | 12700086 | 7 | PS | ACETYLSALICYLIC ACID (} 100 mg) | ASPIRIN | 1 | Unknown | 325 MG, QD | U | 999999 | 325 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127000861 | 12700086 | 1 | Atrial fibrillation |
| 127000861 | 12700086 | 2 | Thrombosis prophylaxis |
| 127000861 | 12700086 | 3 | Cerebrovascular accident prophylaxis |
| 127000861 | 12700086 | 4 | Pain |
| 127000861 | 12700086 | 5 | Product used for unknown indication |
| 127000861 | 12700086 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127000861 | 12700086 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127000861 | 12700086 | Cerebral haemorrhage | |
| 127000861 | 12700086 | Embolic stroke | |
| 127000861 | 12700086 | Haemoptysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127000861 | 12700086 | 1 | 20131114 | 201402 | 0 | |
| 127000861 | 12700086 | 2 | 20140705 | 0 |